These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 38735632)
41. Nanotechnology for Topical Drug Delivery to the Anterior Segment of the Eye. Vaneev A; Tikhomirova V; Chesnokova N; Popova E; Beznos O; Kost O; Klyachko N Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830247 [TBL] [Abstract][Full Text] [Related]
42. Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema. Gao S; Tian B; Han J; Zhang J; Shi Y; Lv Q; Li K Int J Nanomedicine; 2019; 14():6135-6150. PubMed ID: 31447556 [No Abstract] [Full Text] [Related]
43. Potential advantages of a novel chitosan-N-acetylcysteine surface modified nanostructured lipid carrier on the performance of ophthalmic delivery of curcumin. Liu D; Li J; Pan H; He F; Liu Z; Wu Q; Bai C; Yu S; Yang X Sci Rep; 2016 Jun; 6():28796. PubMed ID: 27350323 [TBL] [Abstract][Full Text] [Related]
44. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery. Li H; Chen M; Su Z; Sun M; Ping Q Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421 [TBL] [Abstract][Full Text] [Related]
45. Evaluating the Efficacy of Polyglycolic Acid-Loading Tetrandrine Nanoparticles in the Treatment of Dry Eye. Li T; Tang J; Wu X; Zhang Y; Du Y; Fang Q; Li J; Du Z Ophthalmic Res; 2023; 66(1):1148-1158. PubMed ID: 37690450 [TBL] [Abstract][Full Text] [Related]
46. Novel apigenin-loaded sodium hyaluronate nano-assemblies for targeting tumor cells. Zhao T; He Y; Chen H; Bai Y; Hu W; Zhang L Carbohydr Polym; 2017 Dec; 177():415-423. PubMed ID: 28962787 [TBL] [Abstract][Full Text] [Related]
47. Preparation, characterization and pharmacokinetics of Amoitone B-loaded long circulating nanostructured lipid carriers. Luan J; Zhang D; Hao L; Qi L; Liu X; Guo H; Li C; Guo Y; Li T; Zhang Q; Zhai G Colloids Surf B Biointerfaces; 2014 Feb; 114():255-60. PubMed ID: 24211416 [TBL] [Abstract][Full Text] [Related]
48. Tanshinol borneol ester on nanostructured lipid carriers has longer brain and systemic effector retention and better antioxidant activity in vivo. Yuan X; Fei F; Sun H; Xiao C; Zhao X; Zhang Y; Zheng X Int J Nanomedicine; 2018; 13():2265-2274. PubMed ID: 29695905 [TBL] [Abstract][Full Text] [Related]
50. Formulation And Evaluation Of Nanostructured Lipid Carriers (NLCs) Of 20(S)-Protopanaxadiol (PPD) By Box-Behnken Design. Kim MH; Kim KT; Sohn SY; Lee JY; Lee CH; Yang H; Lee BK; Lee KW; Kim DD Int J Nanomedicine; 2019; 14():8509-8520. PubMed ID: 31749618 [TBL] [Abstract][Full Text] [Related]
51. Fabrication and Characterization of Timolol Maleate and Brinzolamide Loaded Nanostructured Lipid Carrier System for Ocular Drug Delivery. Shrivastava N; Khan S; Baboota S; Ali J Curr Drug Deliv; 2018; 15(6):829-839. PubMed ID: 29189155 [TBL] [Abstract][Full Text] [Related]
52. Design and evaluation of lipoprotein resembling curcumin-encapsulated protein-free nanostructured lipid carrier for brain targeting. Meng F; Asghar S; Xu Y; Wang J; Jin X; Wang Z; Wang J; Ping Q; Zhou J; Xiao Y Int J Pharm; 2016 Jun; 506(1-2):46-56. PubMed ID: 27094357 [TBL] [Abstract][Full Text] [Related]
53. Impact of Nanostructured Lipid Carriers as an Artificial Tear Film in a Rabbit Evaporative Dry Eye Model. Niamprem P; Teapavarapruk P; Srinivas SP; Tiyaboonchai W Cornea; 2019 Apr; 38(4):485-491. PubMed ID: 30681516 [TBL] [Abstract][Full Text] [Related]
54. Loteprednol-Loaded Nanoformulations for Corneal Delivery by Quality-by-Design Concepts: Optimization, Characterization, and Anti-inflammatory Activity. Uner B; Ozdemir S; Tas C; Uner M; Ozsoy Y AAPS PharmSciTech; 2023 Mar; 24(4):92. PubMed ID: 36977841 [TBL] [Abstract][Full Text] [Related]
56. Dual Drug Loaded Lipid Nanocarrier Formulations for Topical Ocular Applications. Youssef AAA; Dudhipala N; Majumdar S Int J Nanomedicine; 2022; 17():2283-2299. PubMed ID: 35611213 [TBL] [Abstract][Full Text] [Related]
57. Improved anti-obesity effect of herbal active and endogenous lipids co-loaded lipid nanocarriers: Preparation, in vitro and in vivo evaluation. Lacatusu I; Badea N; Udeanu D; Coc L; Pop A; Cioates Negut C; Tanase C; Stan R; Meghea A Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():12-24. PubMed ID: 30889655 [TBL] [Abstract][Full Text] [Related]
58. Nanostructured lipid carrier surface modified with Eudragit RS 100 and its potential ophthalmic functions. Zhang W; Li X; Ye T; Chen F; Yu S; Chen J; Yang X; Yang N; Zhang J; Liu J; Pan W; Kong J Int J Nanomedicine; 2014; 9():4305-15. PubMed ID: 25246787 [TBL] [Abstract][Full Text] [Related]
59. Inhibitory effect of a new orally active cedrol-loaded nanostructured lipid carrier on compound 48/80-induced mast cell degranulation and anaphylactic shock in mice. Chakraborty S; Kar N; Kumari L; De A; Bera T Int J Nanomedicine; 2017; 12():4849-4868. PubMed ID: 28744120 [TBL] [Abstract][Full Text] [Related]
60. Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery. Cirri M; Bragagni M; Mennini N; Mura P Eur J Pharm Biopharm; 2012 Jan; 80(1):46-53. PubMed ID: 21839833 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]